Abstract
Emepronium bromide (Cetiprin) is an anticholinergic agent used therapeutically to reduce urinary frequency. We describe a voluntary overdose, which caused respiratory failure due to neuromuscular paralysis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- HANSSON E., SCHMITERLOW C. G. Biological fate of C14-labelled ethyl (3,3-diphenyl-l-methyl-propyl) dimethylammoniumbromide Cetiprin, a monoquaternary ammonium compound. Acta Pharmacol Toxicol (Copenh) 1961;18:183–190. doi: 10.1111/j.1600-0773.1961.tb00330.x. [DOI] [PubMed] [Google Scholar]
- Sundwall A., Vessman J., Strindberg B. Fate of emepronium in man in relation to its pharmacological effects. Eur J Clin Pharmacol. 1973 Oct;6(3):191–195. doi: 10.1007/BF00558285. [DOI] [PubMed] [Google Scholar]